The free educational program, part of the 2019 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum (Feb. 28 -March 2), aims to inform clinicians about how to best manage MS treatment options given the ever-changing therapeutic landscape.
The satellite symposium, “Interpreting the Therapeutic Landscape in Multiple Sclerosis,” will take place from 6:30 to 7:45 a.m. (CST) March 2, at the Hilton Anatole Governors Lecture Hall in Dallas, Texas.
Treatment options for MS are constantly changing. In the past few years, multiple new treatments have emerged, including novel oral therapies and disease-modifying treatments.
Given these options, clinicians can personalize treatment programs for MS patients now more than ever. That’s because each patient differs in disease severity, treatment effectiveness and tolerability, and considerations for lifestyle, adherence, preferences, and concerns.
To implement new therapies for successful personalized treatment of MS, clinicians need to stay informed about the latest research regarding new therapies that may enhance their patients’ outcomes. For example, failure to initiate an early and effective treatment plan with proven novel therapies can result in missed opportunities to preserve or improve a patient’s long-term health, abilities, and quality of life.
Also, new clinical information is often released about common side effects caused by certain therapies that were not known when the therapeutic was approved. Clinicians must stay informed to best manage these common side effects in the treatment of MS patients.
The symposium will involve in-depth panel discussions of challenging clinical cases and knowledge gaps with an interactive audience response system. Together, experts and the audience will debate how to interpret and apply new MS clinical trial data on the therapeutic landscape.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?